Record #344580 - GSI Repository

SEB

Scalable and Eco-friendly Bioproduction

Grant period	2023-01-01 - 2024-12-31
Funding body	European Union
Call number	HORIZON-EIC-2022-ACCELERATOR-01
Grant number	190139157
Identifier	G:(EU-Grant)190139157

Note: Core Biogenesis uses plant-based expression systems for the very large-scale and high-quality bioproduction of pharmaceutical-grade recombinant proteins. The latter are used as growth factors (GF) in synthetic cell culture media for clinical and commercial scale biomanufacturing of cell therapy. The company has developed a novel advanced proprietary bioprocess integrating breakthrough innovations overcoming major technical issues of plant systems by offering a 25-fold yield increase and a 10-fold cost reduction. Its biomanufacturing platform will enable Core Biogenesis to fully exploit the great potential of plants for large and scalable production capacity as plants are well known to be the most promising system for production upscaling. Core Biogenesis’s ambition is to position itself as the European leader in plant-based biomanufacturing by 2025.

Recent Publications

There are no publications

Record created 2023-08-27, last modified 2023-08-27

Similar records

Add to personal basket
Export as Author List with IDs BibTeX (UTF-8), EndNote XML, EndNote Text, RIS, MARC, Print MARC, MARCXML, DC,
Request correction
Submit fulltext

GSI Homepage \| GSI Library \| English Deutsch \| guest :: login GSI Repository
Search	Submit	Personalize Your alerts Your baskets Your searches	Help